Here's Grail Stock Soared: What Drove the May Rally and Where It's Heading
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
Wondering what do you need to start investing? Discover the essential tools and knowledge required to kickstart your investment journey.
19,065 articlesIn May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
As June begins, NVIDIA has surged to the top of investor lists as the biggest June bet on AI infrastructure, backed b...
Procter & Gamble anchors the dividend-growth crowd with a multi-decade streak and strong cash flow. The plain-as-day ...
In a high-stakes clash of industry voices, Ripple's Brad Garlinghouse pushes back against Jamie Dimon's crypto cautio...
In a crowded low Earth orbit, the real gains come from keeping satellites alive and productive. This article explains...
A private equity veteran, famed for saving Arby’s, now champions a $2.7 billion bid for Pizza Hut. The deal splits be...
Original Medicare continues to exclude routine dental care, leaving retirees to navigate costly implants, crowns and ...
Netflix falls on growth and valuation concerns while iHeartMedia rises on an expanded podcast partnership. The move h...
A social-media frenzy around trillionaire wealth centers on Elon Musk, sparking a debate about how market values, pri...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Verizon fell today after a day of headline-driven moves, including strategic spin-offs and competitive shifts in the ...
A leading venture figure signals a six-day, in-office funding filter, prompting founders to rethink work arrangements...